Found: 17
Select item for more details and to access through your institution.
Effect of Zuranolone vs Placebo in Postpartum Depression: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers.
- Published in:
- Cephalalgia, 2013, v. 33, n. 10, p. 853, doi. 10.1177/0333102413476372
- By:
- Publication type:
- Article
Targeting the Arginine Vasopressin V<sub>1b</sub> Receptor System and Stress Response in Depression and Other Neuropsychiatric Disorders.
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 811, doi. 10.2147/NDT.S402831
- By:
- Publication type:
- Article
Constitutive Activation of Gαs within Forebrain Neurons Causes Deficits in Sensorimotor Gating Because of PKA-Dependent Decreases in cAMP.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 3, p. 577, doi. 10.1038/sj.npp.1301099
- By:
- Publication type:
- Article
Corticosterone Modulates Auditory Gating in Mouse.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 5, p. 897, doi. 10.1038/sj.npp.1300879
- By:
- Publication type:
- Article
Patient Attitudes towards Surgically Implantable, Long-Term Delivery of Psychiatric Medicine.
- Published in:
- Neuropsychopharmacology, 2004, v. 29, n. 5, p. 960, doi. 10.1038/sj.npp.1300385
- By:
- Publication type:
- Article
Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse NI Auditory Evoked Potential.
- Published in:
- Neuropsychopharmacology, 2004, v. 29, n. 4, p. 739, doi. 10.1038/sj.npp.1300376
- By:
- Publication type:
- Article
Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of G<sub>5</sub>α.
- Published in:
- Neuropsychopharmacology, 2004, v. 29, n. 3, p. 494, doi. 10.1038/sj.npp.1300309
- By:
- Publication type:
- Article
Pharmacokinetic and behavioral characterization of a long-term antipsychotic delivery system in rodents and rabbits.
- Published in:
- Psychopharmacology, 2007, v. 190, n. 2, p. 201, doi. 10.1007/s00213-006-0616-8
- By:
- Publication type:
- Article
Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.
- Published in:
- Archives of Women's Mental Health, 2020, v. 23, n. 5, p. 727, doi. 10.1007/s00737-020-01042-y
- By:
- Publication type:
- Article
Brexanolone as adjunctive therapy in super-refractory status epilepticus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pediatric super-refractory status epilepticus treated with allopregnanolone.
- Published in:
- Annals of Neurology, 2014, v. 76, n. 6, p. 911, doi. 10.1002/ana.24295
- By:
- Publication type:
- Article
SAGE-217, A Novel GABA<sub>A</sub> Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Investigación de los circuitos de atención visual en la esquizofrenia mediante resonancia magnética funcional bajo un paradigma de rareza.
- Published in:
- American Journal of Psychiatry - Edición Española, 2007, v. 10, n. 6, p. 345
- By:
- Publication type:
- Article
Brexanolone in Postpartum Depression: Post Hoc Analyses to Help Inform Clinical Decision-Making.
- Published in:
- Journal of Women's Health (15409996), 2021, v. 30, n. 3, p. 385, doi. 10.1089/jwh.2020.8483
- By:
- Publication type:
- Article
A phase 1 double‐blind, placebo‐controlled study of zuranolone (SAGE‐217) in a phase advance model of insomnia in healthy adults.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 1, p. 1, doi. 10.1002/hup.2806
- By:
- Publication type:
- Article
Open-label, proof-of-concept study of brexanolone in the treatment of severe postpartum depression.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2017, v. 32, n. 2, p. n/a, doi. 10.1002/hup.2576
- By:
- Publication type:
- Article